Latest Guide: Usage and Precautions of Acarbose, Miglitol, and Voglibose
α-glucosidase inhibitors (AGI) are classic hypoglycemic agents and are one of the recommended combination therapies in the Chinese T2DM prevention and treatment guidelines (2020 edition). AGI drugs have been widely used in China for nearly 30 years, based on their increasingly rich clinical applications and scientific research evidence. The Endocrine and Metabolism Branch of the … Read more